Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer

References

• American Cancer SocietyCancer Statistics Center Available at: https://cancerstatisticscenter.cancer.org/Accessed August 1, 2016
   Google Scholar
• LemmensVvan SteenbergenLJanssen-HeijnenMMartijnHRuttenHCoeberghJWTrends in colorectal cancer in the south of the Netherlands 1975–2007: rectal cancer survival levels with colon cancer survivalActa Oncol201049678479620429731
   PubMed Web of Science ®Google Scholar
• van der GeestLGLam-BoerJKoopmanMVerhoefCElferinkMAde WiltJHNationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastasesClin Exp Metastasis201532545746525899064
   PubMed Web of Science ®Google Scholar
• ManfrediSBouvierAMLepageCHatemCDancourtVFaivreJIncidence and patterns of recurrence after resection for cure of colonic cancer in a well defined populationBr J Surg20069391115112216804870
   PubMed Web of Science ®Google Scholar
• van GestelYRde HinghIHvan Herk-SukelMPPatterns of metachronous metastases after curative treatment of colorectal cancerCancer Epidemiol201438444845424841870
   PubMed Web of Science ®Google Scholar
• HessKRVaradhacharyGRTaylorSHMetastatic patterns in adenocarcinomaCancer200610671624163316518827
   PubMed Web of Science ®Google Scholar
• HugenNvan de VeldeCJde WiltJHNagtegaalIDMetastatic pattern in colorectal cancer is strongly influenced by histological subtypeAnn Oncol201425365165724504447
   PubMed Web of Science ®Google Scholar
• HennessyBTColemanRLMarkmanMOvarian cancerLancet200937496981371138219793610
   PubMed Web of Science ®Google Scholar
• ThomassenILemmensVENienhuijsSWLuyerMDKlaverYLde HinghIHIncidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based studyPancreas2013421727522850624
   PubMed Web of Science ®Google Scholar
• ThomassenIvan GestelYRvan RamshorstBPeritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factorsInt J Cancer2014134362262823832847
   PubMed Web of Science ®Google Scholar
• ThomassenIVerhoevenRHvan GestelYRvan de WouwAJLemmensVEde HinghIHPopulation-based incidence, treatment and survival of patients with peritoneal metastases of unknown originEur J Cancer2014501505624011935
   PubMed Web of Science ®Google Scholar
• MoranBBarattiDYanTDKusamuraSDeracoMConsensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)J Surg Oncol200898427728218726894
   PubMed Web of Science ®Google Scholar
• LemmensVEKlaverYLVerwaalVJRuttenHJCoeberghJWde HinghIHPredictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based studyInt J Cancer2011128112717272520715167
   PubMed Web of Science ®Google Scholar
• SegelmanJGranathFHolmTMachadoMMahtemeHMartlingAIncidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancerBr J Surg201299569970522287157
   PubMed Web of Science ®Google Scholar
• KerscherAGChuaTCGasserMImpact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decadesBr J Cancer201310871432143923511564
   PubMed Web of Science ®Google Scholar
• SegelmanJAkreOGustafssonUOBottaiMMartlingAIndividualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancerColorectal Dis201416535936724410859
   PubMed Web of Science ®Google Scholar
• KoppeMJBoermanOCOyenWJBleichrodtRPPeritoneal carcinomatosis of colorectal origin: incidence and current treatment strategiesAnn Surg2006243221222216432354
   PubMed Web of Science ®Google Scholar
• KohJLYanTDGlennDMorrisDLEvaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosisAnn Surg Oncol200916232733319050972
   PubMed Web of Science ®Google Scholar
• RekhrajSAzizOPrabhudesaiSCan intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysisAnn Surg Oncol2008151606817909914
   PubMed Web of Science ®Google Scholar
• SloothaakDAMirckBPuntCJIntraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic reviewBr J Cancer201411161112112125025964
   PubMed Web of Science ®Google Scholar
• KlaverCEMustersGDBemelmanWAAdjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trialBMC Cancer20151542826003804
   PubMed Web of Science ®Google Scholar
• FrankoJShiQMeyersJPPrognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseLancet Oncol201617121709171927743922
   PubMed Web of Science ®Google Scholar
• RazenbergLGvan GestelYRCreemersGJVerwaalVJLemmensVEde HinghIHTrends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the NetherlandsEur J Surg Oncol201541446647125680955
   PubMed Web of Science ®Google Scholar
• EliasDLefevreJHChevalierJComplete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal originJ Clin Oncol200927568168519103728
   PubMed Web of Science ®Google Scholar
• KlaverYLSimkensLHLemmensVEOutcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapyEur J Surg Oncol201238761762322572106
   PubMed Web of Science ®Google Scholar
• RazenbergLGvan GestelYRLemmensVEde WiltJHCreemersGJde HinghIHThe prognostic relevance of histological subtype in patients with peritoneal metastases from colorectal cancer: a nationwide population-based studyClin Colorectal Cancer2015144e13e1926140733
   PubMedGoogle Scholar
• SprattJSAdcockRAMuskovinMSherrillWMcKeownJClinical delivery system for intraperitoneal hyperthermic chemotherapyCancer Res19804022562606766084
   PubMed Web of Science ®Google Scholar
• SugarbakerPHPeritonectomy proceduresAnn Surg1995221129427826158
   PubMed Web of Science ®Google Scholar
• CashinPHMahtemeHSpangNCytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: a randomised trialEur J Cancer20165315516226751236
   PubMed Web of Science ®Google Scholar
• VerwaalVJvan RuthSde BreeERandomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancerJ Clin Oncol200321203737374314551293
   PubMed Web of Science ®Google Scholar
• EliasDGillyFBoutitieFPeritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French studyJ Clin Oncol2010281636819917863
   PubMed Web of Science ®Google Scholar
• EsquivelJLowyAMMarkmanMThe American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution evaluation of the peritoneal surface disease severity score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosisAnn Surg Oncol201421134195420124854493
   PubMed Web of Science ®Google Scholar
• GlehenOKwiatkowskiFSugarbakerPHCytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional studyJ Clin Oncol200422163284329215310771
   PubMed Web of Science ®Google Scholar
• KuijpersAMMirckBAalbersAGCytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocolAnn Surg Oncol201320134224423023897008
   PubMed Web of Science ®Google Scholar
• GoereDMalkaDTzanisDIs there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?Ann Surg201325761065107123299520
   PubMed Web of Science ®Google Scholar
• EsquivelJPisoPVerwaalVAmerican Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancerJ Surg Oncol2014110777777825043759
   PubMed Web of Science ®Google Scholar
• SimkensGAvan OudheusdenTRBraamHJTreatment-related mortality after cytoreductive surgery and HIPEC in patients with colorectal peritoneal carcinomatosis is underestimated by conventional parametersAnn Surg Oncol20162319910526148758
   PubMed Web of Science ®Google Scholar
• SimkensGAvan OudheusdenTRLuyerMDSerious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosisAnn Surg Oncol20152282656266225515200
   PubMed Web of Science ®Google Scholar
• JacquetPSugarbakerPHClinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosisCancer Treat Res1996823593748849962
   PubMedGoogle Scholar
• da SilvaRGSugarbakerPHAnalysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancerJ Am Coll Surg2006203687888617116556
   PubMed Web of Science ®Google Scholar
• SimkensGAvan OudheusdenTRNieboerDDevelopment of a prognostic nomogram for patients with peritoneally metastasized colorectal cancer treated with cytoreductive surgery and HIPECAnn Surg Oncol201623134214422127027308
   PubMed Web of Science ®Google Scholar
• CavaliereFDe SimoneMVirziSPrognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.OEur J Surg Oncol201137214815421093205
   PubMed Web of Science ®Google Scholar
• GoereDSouadkaAFaronMExtent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative studyAnn Surg Oncol20152292958296425631064
   PubMed Web of Science ®Google Scholar
• EliasDMarianiACloutierASModified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal originEur J Surg Oncol201440111467147325086990
   PubMed Web of Science ®Google Scholar
• SoussanMDes GuetzGBarrauVComparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancyEur Radiol20122271479148722358428
   PubMed Web of Science ®Google Scholar
• LiJYanRLeiJJiangCComparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysisAbdom Imaging20154072660266625893503
   PubMedGoogle Scholar
• ValleMGarofaloALaparoscopic staging of peritoneal surface malignanciesEur J Surg Oncol200632662562716822641
   PubMed Web of Science ®Google Scholar
• VerwaalVJvan TinterenHvan RuthSZoetmulderFAPredicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapyBr J Surg200491673974615164445
   PubMed Web of Science ®Google Scholar
• GlehenOGillyFNBoutitieFToward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patientsCancer2010116245608561820737573
   PubMed Web of Science ®Google Scholar
• ShenPHawksworthJLovatoJCytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinomaAnn Surg Oncol200411217818614761921
   PubMed Web of Science ®Google Scholar
• KuijpersAMAalbersAGNienhuijsSWImplementation of a standardized HIPEC protocol improves outcome for peritoneal malignancyWorld J Surg201539245346025245434
   PubMed Web of Science ®Google Scholar
• AsanumaDSakabeMKamiyaMSensitive beta-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivoNat Commun20156646325765713
   PubMed Web of Science ®Google Scholar
• BoonstraMCvan DrielPBvan WilligenDMuPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgeryOncotarget2015616142601427325895028
   PubMedGoogle Scholar
• ThomassenIvan GestelYRLemmensVEde HinghIHIncidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal originDis Colon Rectum201356121373138024201391
   PubMed Web of Science ®Google Scholar
• El-NakeepSRashadNOweiraHIntraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic reviewExpert Rev Gastroenterol Hepatol201711324925828099818
   PubMed Web of Science ®Google Scholar
• KwakmanRSchramaAMvan OlmenJPClinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysisAnn Surg201626361102111126756756
   PubMed Web of Science ®Google Scholar
• LorimierGLinotBPaillocherNCurative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancerEur J Surg Oncol201743115015827839895
   PubMed Web of Science ®Google Scholar
• NavezJRemueCLeonardDSurgical treatment of colorectal cancer with peritoneal and liver metastases using combined liver and cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: report from a single-centre experienceAnn Surg Oncol201623Suppl 566667327646023
   PubMed Web of Science ®Google Scholar
• RandleRWDoudANLevineEAPeritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Ann Surg Oncol20152251634163825120252
   PubMed Web of Science ®Google Scholar
• EliasDFaronMGoereDA simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastasesAnn Surg Oncol20142162052205824499829
   PubMed Web of Science ®Google Scholar
• SimkensGARazenbergLGLemmensVERuttenHJCreemersGJde HinghIHHistological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastasesEur J Surg Oncol201642679480027055946
   PubMed Web of Science ®Google Scholar
• van OudheusdenTRBraamHJNienhuijsSWPoor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histologyJ Surg Oncol2015111223724225195780
   PubMed Web of Science ®Google Scholar
• WinerJZenatiMRamalingamLImpact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal originAnn Surg Oncol20142151456146224201745
   PubMed Web of Science ®Google Scholar
• ChuaTCPelzJOKerscherAMorrisDLEsquivelJCritical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinomaAnn Surg Oncol200916102765277019641972
   PubMed Web of Science ®Google Scholar
• Van SweringenHLHansemanDJAhmadSAEdwardsMJSussmanJJPredictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapySurgery2012152461762422943843
   PubMed Web of Science ®Google Scholar
• PelzJOStojadinovicANissanAHohenbergerWEsquivelJEvaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosisJ Surg Oncol200999191518937291
   PubMed Web of Science ®Google Scholar
• van ErningFNvan SteenbergenLNLemmensVEConditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?Eur J Cancer201450101731173924814358
   PubMed Web of Science ®Google Scholar
• Van LeersumNJSnijdersHSHennemanDThe Dutch surgical colorectal auditEur J Surg Oncol201339101063107023871573
   PubMed Web of Science ®Google Scholar
• SimkensGAvan OudheusdenTRBraamHJCytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control studyJ Surg Oncol2016113554855327110701
   PubMed Web of Science ®Google Scholar
• UngLChuaTCMorrisDLPeritoneal metastases of lower gastrointestinal tract origin: a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapyJ Cancer Res Clin Oncol2013139111899190824052322
   PubMed Web of Science ®Google Scholar
• VotanopoulosKISwettKBlackhamAUCytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancerAnn Surg Oncol20132041088109223456381
   PubMed Web of Science ®Google Scholar
• Gomes da SilvaRCabanasJSugarbakerPHLimited survival in the treatment of carcinomatosis from rectal cancerDis Colon Rectum200548122258226316228825
   PubMed Web of Science ®Google Scholar
• RivardJDMcConnellYJTempleWJMackLACytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: are we excluding patients who may benefit?J Surg Oncol2014109210410924449172
   PubMed Web of Science ®Google Scholar
• KlaverYLLemmensVENienhuijsSWNieuwenhuijzenGARuttenHJde HinghIHIntraoperative radiotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Five consecutive case reports of locally advanced rectal cancer with synchronous peritoneal carcinomatosisStrahlenther Onkol2013189325626023329276
   PubMed Web of Science ®Google Scholar
• PassotGVaudoyerDCotteEProgression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosisAnn Surg2012256112512922580942
   PubMed Web of Science ®Google Scholar
• BarattiDKusamuraSIuscoDPostoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patientsDis Colon Rectum201457785886824901687
   PubMed Web of Science ®Google Scholar
• DevileeRASimkensGAvan OudheusdenTRIncreased survival of patients with synchronous colorectal peritoneal metastases receiving preoperative chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapyAnn Surg Oncol20162392841284827044447
   PubMed Web of Science ®Google Scholar
• CeelenWVan NieuwenhoveYPutteDVPattynPNeoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosisAnn Surg Oncol20142193023302824756812
   PubMed Web of Science ®Google Scholar
• PassotGYouBBoschettiGPathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosisAnn Surg Oncol20142182608261424668148
   PubMed Web of Science ®Google Scholar
• BlazerDG3rdKishiYMaruDMPathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastasesJ Clin Oncol200826335344535118936472
   PubMed Web of Science ®Google Scholar
• ChanGHassanainMChaudhuryPPathological response grade of colorectal liver metastases treated with neoadjuvant chemotherapyHPB (Oxford)201012427728420590898
   PubMed Web of Science ®Google Scholar
• NordlingerBSorbyeHGlimeliusBPerioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trialLancet200837196171007101618358928
   PubMed Web of Science ®Google Scholar
• ChuaTCMorrisDLSaxenaAInfluence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter studyAnn Surg Oncol20111861560156721203904
   PubMed Web of Science ®Google Scholar
• Prada-VillaverdeAEsquivelJLowyAMThe American Society of Peritoneal Surface Malignancies evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgeryJ Surg Oncol2014110777978525088304
   PubMed Web of Science ®Google Scholar
• NgJLOngWSChiaCSTanGHSooKCTeoMCPrognostic relevance of the peritoneal surface disease severity score compared to the peritoneal cancer index for colorectal peritoneal carcinomatosisInt J Surg Oncol20162016249513127006828
   PubMedGoogle Scholar
• RoversKPSimkensGAPuntCJvan DierenSTanisPJde HinghIHPerioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic reviewCrit Rev Oncol Hematol2017114536228477747
   PubMed Web of Science ®Google Scholar